Amgen, Inc. (AMGN), Transcept Pharmaceuticals Incorporated (TSPT), Urban Outfitters, Inc. (URBN), Ameren Co. (AEE), Ameriprise Financial, Inc. (AMP) and Alimera Sciences Inc. (ALIM) ratings and price targets.
Piper Jaffray (NYSE:PJC) downgraded Amgen, Inc. (AMGN) from an “Overweight” rating to a “Neutral” rating. They have a price target of $65.00 on the company.
McNicoll Lewis & Vlak reiterated its “Buy” rating on Transcept Pharmaceuticals Incorporated (TSPT). They have a price target of $21.00 on the company.
Bank of America (NYSE:BAC) reiterated its “Buy” rating on Urban Outfitters, Inc. (URBN). They have a price target of $32.00 on the company.
Goldman Sachs (NYSE:GS) upgraded Ameren Co. (AEE) from a “Sell” rating to a “Neutral” rating.
Credit Suisse (NYSE:CS) downgraded Alimera Sciences Inc. (ALIM) from an “Outperform” rating to a “Neutral” rating. They have a price target of $2.00 on the company.
Goldman Sachs reiterated its “Buy” rating on Ameriprise Financial, Inc. (AMP). They have a price target of $60.00 on the company.
Tuesday, November 15, 2011
Amgen (AMGN) (TSPT) (URBN) (AEE) (AMP) (ALIM) Ratings, Price Targets
Labels:
Bank of America
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment